: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Cervical Cancer, March 2021
Free Subscription

Abstracts
Retrieve all available abstracts of the following 355 articles:
HTML format

Single Articles

HUANG X, Liu X, Du B, Liu X, et al
LncRNA LINC01305 promotes cervical cancer progression through KHSRP and exosome-mediated transfer.
Aging (Albany NY). 2021;13.
PubMed
Abstract available

JORGENSEN SF, Andersen B, Rebolj M, Njor SH, et al
Gaps between recommendations and their implementation: A register-based study of follow-up after abnormalities in cervical cancer screening.
Prev Med. 2021 Feb 23:106468. doi: 10.1016/j.ypmed.2021.106468.
PubMed
Abstract available

KIM SI, Kim TH, Lee M, Kim HS, et al
Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy.
Yonsei Med J. 2021;62:231-239.
PubMed
Abstract available

KONG X, Wang JS, Yang H
Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
J Biochem Mol Toxicol. 2021 Feb 25:e22749. doi: 10.1002/jbt.22749.
PubMed
Abstract available

LOURENCO DE FREITAS N, Deberaldini MG, Gomes D, Pavan AR, et al
Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus.
Front Cell Dev Biol. 2021;8:592868.
PubMed
Abstract available

SUN Y, Zhang R, Zhou S, Ji Y, et al
Erratum: Overexpression of Notch1 is associated with the progression of cervical cancer.
Oncol Lett. 2021;21:134.
PubMed
Abstract available

SHI H, Zhong F, Yi X, Shi Z, et al
Application of an Autophagy-Related Gene Prognostic Risk Model Based on TCGA Database in Cervical Cancer.
Front Genet. 2021;11:616998.
PubMed
Abstract available

GHANAAT M, Goradel NH, Arashkia A, Ebrahimi N, et al
Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer.
Acta Pharmacol Sin. 2021 Feb 25. pii: 10.1038/s41401-021-00616.
PubMed
Abstract available

FARAHAT FM, Faqih NT, Alharbi RS, Mudarris RI, et al
Epidemiological characteristics of cervical cancer in a tertiary care hospital, western Saudi Arabia: A retrospective record-based analysis from 2002-2018.
Saudi Med J. 2021;42:338-341.
PubMed
Abstract available

MOSCICKI AB, Chang C, Vangala S, Zhou X, et al
Effect of 2 Interventions on Cervical Cancer Screening Guideline Adherence.
Am J Prev Med. 2021 Feb 22. pii: S0749-3797(21)00057.
PubMed
Abstract available

ZHANG Y, Qiu S, Guo Y, Zhang J, et al
Diagnostic Value of Vaginal Microecology, Serum miR-18a, and PD-L1 for Identifying HPV-Positive Cervical Cancer.
Technol Cancer Res Treat. 2021;20:1533033821995281.
PubMed
Abstract available

ZHANG Y, Lu H, Zhang J, Wang S, et al
Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Future Oncol. 2021 Feb 26. doi: 10.2217/fon-2020-1024.
PubMed
Abstract available

KUROKI L, Massad LS, Martin A, Liu J, et al
Addressing Unmet Basic Needs to Improve Colposcopy Adherence Among Women With Abnormal Cervical Cancer Screening.
J Low Genit Tract Dis. 2021 Feb 25. pii: 00128360-900000000-99356.
PubMed
Abstract available

JODRY D, Blemur D, Nguyen ML, Kuhn T, et al
Criminal Justice Involvement and Abnormal Cervical Cancer Screening Results Among Women in an Urban Safety Net Hospital.
J Low Genit Tract Dis. 2021 Feb 25. pii: 00128360-900000000-99354.
PubMed
Abstract available

LONG ME, Chantigian PDM, Weaver AL
Would Women With Solid Organ Transplant Qualify for Triennial Cervical Cancer Screening as Recommended by the American College of Obstetricians and Gynecologists in 2016 and American Society for Colposcopy and Cervical Pathology in 2019?
J Low Genit Tract Dis. 2021 Feb 25. pii: 00128360-900000000-99353.
PubMed
Abstract available

FAN Q, Huang T, Sun X, Wang YW, et al
HPV-16/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1.
Mol Carcinog. 2021 Feb 25. doi: 10.1002/mc.23292.
PubMed
Abstract available

EBELL MH
HPV Vaccine, Especially Before Age 17, Is Associated with a Large Reduction in Invasive Cervical Cancer.
Am Fam Physician. 2021;103:312.
PubMed

JACOB RA, Abraham PS, Thomas FR, Navya V, et al
Impact of indirect education on knowledge and perception on cervical cancer and its prevention among the parents of adolescent girls: an interventional school-based study.
Ther Adv Vaccines Immunother. 2021;9:2515135521990268.
PubMed
Abstract available

DEGUARA M, Calleja N, England K
Cervical cancer and screening: knowledge, awareness and attitudes of women in Malta.
J Prev Med Hyg. 2021;61:E584-E592.
PubMed
Abstract available

YANG B, Chen J, Teng Y
CDK12 Promotes Cervical Cancer Progression through Enhancing Macrophage Infiltration.
J Immunol Res. 2021;2021:6645885.
PubMed
Abstract available

MORGAN EL, Patterson MR, Barba-Moreno D, Scarth JA, et al
The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer.
Oncogene. 2021 Feb 24. pii: 10.1038/s41388-021-01679.
PubMed
Abstract available

SONG L, Ding L, Feng MJ, Li XX, et al
[Effects of hnRNP E1 on expression of early genes E2, E6 of HPV16 and biological function in cervical cancer cells].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42:321-326.
PubMed
Abstract available

FU Q, Xu Y, Zuo J, An J, et al
Comparison of two inverse planning algorithms for cervical cancer brachytherapy.
J Appl Clin Med Phys. 2021 Feb 24. doi: 10.1002/acm2.13195.
PubMed
Abstract available

BIZZARRI N, Pedone Anchora L, Ferrandina G, Scambia G, et al
ASO Author Reflections: Conization Before Radical Hysterectomy Improves Disease-Free Survival in Early Stage Cervical Cancer.
Ann Surg Oncol. 2021 Feb 24. pii: 10.1245/s10434-021-09697.
PubMed

LI Z, Chen J, Zhao S, Li Y, et al
Discovery and validation of novel biomarkers for detection of cervical cancer.
Cancer Med. 2021 Feb 23. doi: 10.1002/cam4.3799.
PubMed
Abstract available

XU W, Xie S, Chen X, Pan S, et al
Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells.
Drug Des Devel Ther. 2021;15:577-588.
PubMed
Abstract available

PALAIA I, Tomao F, DI Pinto A, Pernazza A, et al
Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors.
In Vivo. 2021;35:1277-1283.
PubMed
Abstract available

MUKAI Y, Yokota NR, Sugiura M, Mizushima T, et al
Outcome of Radiation Therapy for Stage IVB Uterine Cervical Cancer With Distant Lymph Nodes Metastases; Sequential Irradiation for Distant Lymph Nodes Metastases.
In Vivo. 2021;35:1169-1176.
PubMed
Abstract available

CHUNG YK, Lee YK, Yoon BH, Suh DH, et al
Pelvic Insufficiency Fractures in Cervical Cancer After Radiation Therapy: A Meta-Analysis and Review.
In Vivo. 2021;35:1109-1115.
PubMed
Abstract available

ZHANG L, Wu X, Li Y, Teng X, et al
LncRNA SNHG5 promotes cervical cancer progression by regulating the miR-132/SOX4 pathway.
Autoimmunity. 2021 Feb 23:1-9. doi: 10.1080/08916934.2020.1864731.
PubMed
Abstract available

MOISE RK, Jonas E, Campa EM, Clisbee M, et al
Bayo Lapawol (Let Their Voices Be Heard): Haitian Women's Barriers to and Facilitators of Cervical Cancer Prevention and Control.
Health Educ Behav. 2021 Feb 23:1090198121990381. doi: 10.1177/1090198121990381.
PubMed
Abstract available

SHEN X, Li L, He Y, Lv X, et al
Raddeanin A inhibits proliferation, invasion, migration and promotes apoptosis of cervical cancer cells via regulating miR-224-3p/Slit2/Robo1 signaling pathway.
Aging (Albany NY). 2021;13.
PubMed
Abstract available

KURIAN R, Kirchhoff-Rowald A, Sahil S, Cheng AL, et al
The Risk of Primary Uterine and Cervical Cancer After Hysteropexy.
Female Pelvic Med Reconstr Surg. 2021;27:e493-e496.
PubMed
Abstract available

BIZZARRI N, Pedone Anchora L, Kucukmetin A, Ratnavelu N, et al
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study.
Ann Surg Oncol. 2021 Feb 23. pii: 10.1245/s10434-021-09695.
PubMed
Abstract available

GELDSETZER P, Lemp JM
Cervical Cancer Screening in Low- and Middle-Income Countries-Reply.
JAMA. 2021;325:790-791.
PubMed

CREMER M, Alfaro K, Masch R
Cervical Cancer Screening in Low- and Middle-Income Countries.
JAMA. 2021;325:790.
PubMed

DENG C, Ding D, Wang M
The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB~IVA cervical cancer.
Postgrad Med. 2021 Feb 23. doi: 10.1080/00325481.2021.1894823.
PubMed
Abstract available

MORCOS M, Viswanathan AN, Enger SA
On the impact of absorbed dose specification, tissue heterogeneities and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75 and Yb-169 in conventional and intensity modulated brachytherapy for the treatment of cervical cancer.
Med Phys. 2021 Feb 22. doi: 10.1002/mp.14802.
PubMed
Abstract available

XING Y, Chen L, Gu H, Yang C, et al
Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
Oncogene. 2021 Feb 22. pii: 10.1038/s41388-021-01693.
PubMed
Abstract available

SIMS TT, El Alam MB, Karpinets TV, Dorta-Estremera S, et al
Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation.
Commun Biol. 2021;4:237.
PubMed
Abstract available

GUO C, Wang J, Wang Y, Qu X, et al
Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: A multi-institutional study.
Transl Oncol. 2021;14:101032.
PubMed
Abstract available

WU X, Wu L, Han J, Wu Y, et al
Evaluation of the sexual quality of life and sexual function of cervical cancer survivors after cancer treatment: a retrospective trial.
Arch Gynecol Obstet. 2021 Feb 22. pii: 10.1007/s00404-021-06005.
PubMed
Abstract available

MA X, Wu Z, Zhang J, Shao X, et al
Increased ADAM12 Expression Predicts Poor Prognosis in Cervical Cancer Patients before General Anesthesia.
Clin Lab. 2021;67.
PubMed
Abstract available

JI M, Na N, Lin S
Diagnostic Value of Serum N1-Methylnicotinamide in Cervical Cancer Patients.
Clin Lab. 2021;67.
PubMed
Abstract available

HAN HY, Mou JT, Jiang WP, Zhai XM, et al
Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer.
Biosci Rep. 2021 Feb 22. pii: 227898. doi: 10.1042/BSR20204394.
PubMed
Abstract available

GHISU GP
[Importance of the Pap smear in the age of HPV testing].
Ther Umsch. 2021;78:93-98.
PubMed
Abstract available

TANG X, Wen X, Li Z, Wen D, et al
Hsa_circ_0102171 aggravates the progression of cervical cancer through targeting miR-4465/CREBRF axis.
J Cell Physiol. 2020 Dec 7. doi: 10.1002/jcp.30210.
PubMed
Abstract available

MOUSAVI SZ, Poortahmasebi V, Mokhtari-Azad T, Shahmahmoodi S, et al
The dysregulation of microarray gene expression in cervical cancer is associated with overexpression of a unique messenger RNA signature.
Iran J Microbiol. 2020;12:629-635.
PubMed
Abstract available

ZHENG Q, Chen X, Han R, Zhu J, et al
HPV58 E7 Protein Expression Profile in Cervical Cancer and CIN with Immunohistochemistry.
J Cancer. 2021;12:1722-1728.
PubMed
Abstract available

TAKAHASHI M, Sakai K, Iwasa N, Wada M, et al
Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
J Obstet Gynaecol Res. 2021 Feb 21. doi: 10.1111/jog.14713.
PubMed
Abstract available

TAGUCHI A, Nakajima Y, Furusawa A, Yoshino Y, et al
High neutrophil-to-lymphocyte ratio is a predictor of short-term survival for patients with recurrent cervical cancer after radiation-based therapy.
J Obstet Gynaecol Res. 2021 Feb 21. doi: 10.1111/jog.14712.
PubMed
Abstract available

ANTINYAN A, Bertoni M, Corazzini L
Cervical cancer screening invitations in low and middle income countries: Evidence from Armenia.
Soc Sci Med. 2021;273:113739.
PubMed
Abstract available

GU H, Wen J
Abnormal level of paxillin in cervical cancer cells is involved in tumor progression and invasion.
Acta Biochim Pol. 2021 Feb 20. pii: 5379. doi: 10.18388/abp.2020_5379.
PubMed
Abstract available

O'FLYNN H, Ryan NAJ, Narine N, Shelton D, et al
Diagnostic accuracy of cytology for the detection of endometrial cancer in urine and vaginal samples.
Nat Commun. 2021;12:952.
PubMed
Abstract available

MA C, Huang Z, Wu Z, Di C, et al
Overexpression of FUBP1 is associated with human cervical carcinoma development and prognosis.
Life Sci. 2021;269:119098.
PubMed
Abstract available

XUE P, Tang C, Li Q, Li Y, et al
Development and validation of an artificial intelligence system for grading colposcopic impressions and guiding biopsies.
BMC Med. 2020;18:406.
PubMed
Abstract available

MAHALINGAM S, Sundaramurthi S, Krishnaraj B, Sistla SC, et al
Radiation-induced sarcoma presenting as a gluteal abscess: a diagnostic and therapeutic challenge.
BMJ Case Rep. 2020;13.
PubMed
Abstract available

ALMUSALAM L, Alghtani N, Alkushi A, Arabi H, et al
Uterine cervix rhabdomyosarcoma: an uncommon entity in an adult patient.
BMJ Case Rep. 2020;13.
PubMed
Abstract available

TAGHAVI K, Rohner E, Basu P, Low N, et al
Screening test accuracy of portable devices that can be used to perform colposcopy for detecting CIN2+ in low- and middle-income countries: a systematic review and meta-analysis.
BMC Womens Health. 2020;20:253.
PubMed
Abstract available

KATERJI M, Filippova M, Wongworawat YC, Siddighi S, et al
Oxidative stress markers in patient-derived non-cancerous cervical tissues and cells.
Sci Rep. 2020;10:19044.
PubMed
Abstract available

KURMYSHKINA O, Kovchur P, Schegoleva L, Volkova T, et al
Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Int J Mol Sci. 2020;21.
PubMed
Abstract available

MORGAN EL, Macdonald A
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
Viruses. 2020;12.
PubMed
Abstract available

HERNANDEZ N, Desroches B, Peden E, Satkunasivam R, et al
Uretero-Iliac artery fistula: a rare cause of haematuria.
BMJ Case Rep. 2020;13.
PubMed
Abstract available

CHEN J, Qiu J, Li F, Jiang X, et al
HN1 promotes tumor associated lymphangiogenesis and lymph node metastasis via NF-kappaB signaling activation in cervical carcinoma.
Biochem Biophys Res Commun. 2020;530:87-94.
PubMed
Abstract available

RUAN M, Cheng Q, Gong C, Cao Z, et al
Development of a kind of RG108-Fluorescein conjugates for detection of DNA methyltransferase 1 (DNMT1) in living cells.
Anal Biochem. 2020;607:113823.
PubMed
Abstract available

ZHANG H, Pradhan D, Wang T, Ashman D, et al
Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital.
Cancer Cytopathol. 2020;128:852-859.
PubMed
Abstract available

RAMIREZ-PALACIOS P, Chen A, Flores YN, Crespi CM, et al
Benefit of double-reading cytology smears as a triage strategy among high-risk human papillomavirus-positive women in Mexico.
Cancer Cytopathol. 2020;128:715-724.
PubMed
Abstract available

CORDOVA-RIVAS S, Araujo-Huitrado JG, Rivera-Avalos E, Escalante-Garcia IL, et al
Differential Proliferation Effect of the Newly Synthesized Valine, Tyrosine and Tryptophan-Naphthoquinones in Immortal and Tumorigenic Cervical Cell Lines.
Molecules. 2020;25.
PubMed
Abstract available

AVELINO KYPS, Oliveira LS, Lucena-Silva N, de Melo CP, et al
Metal-polymer hybrid nanomaterial for impedimetric detection of human papillomavirus in cervical specimens.
J Pharm Biomed Anal. 2020;185:113249.
PubMed
Abstract available

MURENZI G, Kanyabwisha F, Murangwa A, Kubwimana G, et al
Twelve-year trend in the prevalence of high-risk human papillomavirus infection among Rwandan women living with HIV.
J Infect Dis. 2020 Feb 12. pii: 5734756. doi: 10.1093.
PubMed
Abstract available

CHUA GT, Ho FK, Tung KT, Wong RS, et al
Sexual behaviors and intention for cervical screening among HPV-vaccinated young Chinese females.
Vaccine. 2019 Nov 27. pii: S0264-410X(19)31573.
PubMed
Abstract available

HE M, Wang Y, Cai J, Xie Y, et al
LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway.
Exp Cell Res. 2021 Mar 3:112551. doi: 10.1016/j.yexcr.2021.112551.
PubMed
Abstract available

ZHU Y, Ren C, Jiang D, Yang L, et al
RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
Cancer Sci. 2021 Mar 6. doi: 10.1111/cas.14874.
PubMed
Abstract available

TORNE A, Pahisa J, Ordi J, Fuste P, et al
Oncological Results of Laparoscopically Assisted Radical Vaginal Hysterectomy in Early-Stage Cervical Cancer: Should We Really Abandon Minimally Invasive Surgery?
Cancers (Basel). 2021;13.
PubMed
Abstract available

WANG Q, Vattai A, Vilsmaier T, Kaltofen T, et al
Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
Int J Mol Sci. 2021;22.
PubMed
Abstract available

DA MATA S, Ferreira J, Nicolas I, Esteves S, et al
P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
Int J Mol Sci. 2021;22.
PubMed
Abstract available

DEMING AC, Wellehan JFX, Colegrove KM, Hall A, et al
Unlocking the Role of a Genital Herpesvirus, Otarine Herpesvirus 1, in California Sea Lion Cervical Cancer.
Animals (Basel). 2021;11.
PubMed
Abstract available

JOHNSON CJ, Morawski BM, Hobbs L, Lewis D, et al
Time from breast cancer diagnosis to treatment among Idaho's National Breast and Cervical Cancer Early Detection Program population, 2011-2017.
Cancer Causes Control. 2021 Mar 4. pii: 10.1007/s10552-021-01407.
PubMed
Abstract available

XU Y, Luo H, Hu Q, Zhu H, et al
Identification of Potential Driver Genes Based on Multi-Genomic Data in Cervical Cancer.
Front Genet. 2021;12:598304.
PubMed
Abstract available

NAGELHOUT G, Ebisch RM, Van Der Hel O, Meerkerk GJ, et al
Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis.
Expert Rev Anticancer Ther. 2021 Mar 5:1-14. doi: 10.1080/14737140.2021.1888719.
PubMed
Abstract available

CHEN J, Cao YJ, Zhu L, Zhang BL, et al
[Clinical observational study of Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer].
Zhonghua Yi Xue Za Zhi. 2021;101:597-601.
PubMed
Abstract available

CHUAI Y, Rizzuto I, Zhang X, Li Y, et al
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.
Cochrane Database Syst Rev. 2021;3:CD013348.
PubMed
Abstract available

ZHU J, Han S
Downregulation of LncRNA DARS-AS1 Inhibits the Tumorigenesis of Cervical Cancer via Inhibition of IGF2BP3.
Onco Targets Ther. 2021;14:1331-1340.
PubMed
Abstract available

PKHAKADZE G, Bokhua Z, Asatiani T, Muzashvili T, et al
STEM CELL INDEX IN THE PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA.
Georgian Med News. 2021;:157-164.
PubMed
Abstract available

WANG Q, Yen YT, Xie C, Liu F, et al
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
Drug Deliv. 2021;28:510-519.
PubMed
Abstract available

FAN WJ, Ding H, Chen XX, Yang L, et al
All-Trans Retinoic Acid Potentiates Antitumor Efficacy of Cisplatin by Increasing Differentiation of Cancer Stem-Like Cells in Cervical Cancer.
Ann Clin Lab Sci. 2021;51:22-29.
PubMed
Abstract available

XIA C, Xu X, Zhao X, Hu S, et al
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study.
BMC Med. 2021;19:62.
PubMed
Abstract available

AKWIDITYA MA, Yong CY, Yusof MT, Mariatulqabtiah AR, et al
Hepatitis B Virus-Like Particle: Targeted Delivery of Plasmid Expressing Short Hairpin RNA for Silencing the Bcl-2 Gene in Cervical Cancer Cells.
Int J Mol Sci. 2021;22.
PubMed
Abstract available

WANG J, Wu Y, Li Y, Wang Y, et al
Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway.
Int J Oncol. 2021;58:1.
PubMed
Abstract available

SHAO X, Zheng X, Ma D, Liu Y, et al
Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
Biosci Rep. 2021 Mar 1. pii: 227998. doi: 10.1042/BSR20200533.
PubMed
Abstract available

ZHANG J, Rashmi R, Inkman M, Jayachandran K, et al
Integrating imaging and RNA-seq improves outcome prediction in cervical cancer.
J Clin Invest. 2021;131.
PubMed
Abstract available

HU Q, Ke G
Intravesical Instillation of Kangfuxin Liquid Combined with Thrombin and Epidermal Growth Factor for Radiation-induced Hemorrhagic Cystitis in Patients with Cervical Cancer: A report of 34 cases.
Bioengineered. 2021;12:815-820.
PubMed
Abstract available

MOUSAVI AS, Pouryasin A, Yarandi F, Pirzadeh L, et al
Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women.
Iran J Public Health. 2020;49:1734-1742.
PubMed
Abstract available

PUSPITASARI IM, Legianawati D, Sinuraya RK, Suwantika AA, et al
Cost-Effectiveness Analysis of Chemoradiation and Radiotherapy Treatment for Stage IIB and IIIB Cervical Cancer Patients.
Int J Womens Health. 2021;13:221-229.
PubMed
Abstract available

KATANYOO K, Thavaramara T
Clinical Impact of Pelvic Lymph Node Status in Locally Advanced Cervical Cancer Patients Treated by Concurrent Chemoradiation Therapy.
Asian Pac J Cancer Prev. 2021;22:491-497.
PubMed
Abstract available

JOSHI S, Muwonge R, Kulkarni V, Lucas E, et al
Mobile Screening Unit (MSU) for the Implementation of the 'Screen and Treat' Programme for Cervical Cancer Prevention In Pune, India.
Asian Pac J Cancer Prev. 2021;22:413-418.
PubMed
Abstract available

SOLDEVILA-LOZANO C, Sabate-Llobera A, Robles-Barba JJ, Mestres-Marti J, et al
Mediastinal Recurrence of Uterine Cervix Cancer on 18F-FDG PET/CT.
Clin Nucl Med. 2021 Jan 19. pii: 00003072-900000000-96246.
PubMed
Abstract available

VAHABI M, Lofters AK, Kopp A, Glazier RH, et al
Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada.
Cancer Causes Control. 2021;32:147-155.
PubMed
Abstract available

MACDONALD EJ, Geller S, Sibanda N, Stevenson K, et al
Reaching under-screened/never-screened indigenous peoples with human papilloma virus self-testing: A community-based cluster randomised controlled trial.
Aust N Z J Obstet Gynaecol. 2021;61:135-141.
PubMed
Abstract available

SITARESMI MN, Rozanti NM, Simangunsong LB, Wahab A, et al
Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.
BMC Public Health. 2020;20:1836.
PubMed
Abstract available

TUGWELL P, Andre Knottnerus J
Cervical screening and overdiagnosis: continuation of Controversy and Debate.
J Clin Epidemiol. 2020;127:A8-A10.
PubMed

KNOTTNERUS JA, Tugwell P
Editors Epilogue; Looking back and forward in the arena of screening, overdiagnosis, and optimizing outcome: editors' epilogue.
J Clin Epidemiol. 2020;127:244-245.
PubMed

CHALMERS I
Response to above Commentaries and Letters by defenders of the inquiry into the management of cervical carcinoma in situ in National Women's Hospital, New Zealand, in the 1960s and early 1970s.
J Clin Epidemiol. 2020;127:241-243.
PubMed

RAFFLE AE, Gray JAM
Response to above Commentaries and Letters by the authors of "The 1960s cervical screening incident at National Women's Hospital, Auckland, New Zealand: insights for screening research, policy making, and practice".
J Clin Epidemiol. 2020;127:237-240.
PubMed

SKEGG DCG
Letter to the editor: The 1960s cervical screening incident at National Women's Hospital, Auckland, New Zealand.
J Clin Epidemiol. 2020;127:235-236.
PubMed

JONES RW
Letter to the editor: A clinician's perspective of the 'unfortunate experiment'.
J Clin Epidemiol. 2020;127:229-230.
PubMed

WELLER DP, Elfstrom KM
Commentary: Back to the future in cervical screening: applying a contemporary lens to an old controversy.
J Clin Epidemiol. 2020;127:218-219.
PubMed

MURAKAMI T, Takasawa A, Takasawa K, Akimoto T, et al
Aberrant expression of junctional adhesion molecule-A contributes to the malignancy of cervical adenocarcinoma by interaction with poliovirus receptor/CD155.
Cancer Sci. 2021;112:906-917.
PubMed
Abstract available

IKEDA S, Ueda Y, Hara M, Yagi A, et al
Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case-control study.
Cancer Sci. 2021;112:839-846.
PubMed
Abstract available

TAGHINEZHAD-S S, Keyvani H, Bermudez-Humaran LG, Donders GGG, et al
Twenty years of research on HPV vaccines based on genetically modified lactic acid bacteria: an overview on the gut-vagina axis.
Cell Mol Life Sci. 2021;78:1191-1206.
PubMed
Abstract available

PEARLMAN PC
Promise of Smartphone-Enabled Teleconsultation for Global Cancer Prevention.
JCO Glob Oncol. 2020;6:1389-1391.
PubMed

GILHAM C
Implications for women testing positive for human papillomavirus.
BJOG. 2021;128:755.
PubMed

COSTA PA, Needelman BS, Tjendra Y, Hoffman JE, et al
High-grade B-cell lymphoma with MYC and BCL6 rearrangements presenting as a cervical mass.
BMJ Case Rep. 2020;13.
PubMed
Abstract available

BENNETT KF, Waller J, McBride E, Forster AS, et al
Psychosexual distress following routine primary human papillomavirus testing: a longitudinal evaluation within the English Cervical Screening Programme.
BJOG. 2021;128:745-754.
PubMed
Abstract available

MATSUURA Y, Noguchi A, Sakai S, Yokota N, et al
Nuclear accumulation of ZFP36L1 is cell cycle-dependent and determined by a C-terminal serine-rich cluster.
J Biochem. 2020;168:477-489.
PubMed
Abstract available

WILLYSSON A, Stahl AL, Gillet D, Barbier J, et al
Shiga Toxin Uptake and Sequestration in Extracellular Vesicles Is Mediated by Its B-Subunit.
Toxins (Basel). 2020;12.
PubMed
Abstract available

SINGH G, Nenavathu BP, Imtiyaz K, Moshahid A Rizvi M, et al
Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
Biomed Pharmacother. 2020;129:110443.
PubMed
Abstract available

XU H, Wang L, Shi B, Hu L, et al
Caffeine inhibits the anticancer activity of paclitaxel via down-regulation of alpha-tubulin acetylation.
Biomed Pharmacother. 2020;129:110441.
PubMed
Abstract available

FAVELA-BUENO J, Perez-Morales R, Ramirez-Torres J, Hernandez-Arteaga L, et al
Identification of Multiple High-Risk Human Papillomavirus Infections in a Rural Population of Canatlan, Durango, Mexico.
Genet Test Mol Biomarkers. 2020;24:370-374.
PubMed
Abstract available

HOLUBEKOVA V, Mersakova S, Grendar M, Snahnicanova Z, et al
The Role of CADM1 and MAL Promoter Methylation in Inflammation and Cervical Intraepithelial Neoplasia.
Genet Test Mol Biomarkers. 2020;24:256-263.
PubMed
Abstract available

BAYRAMOGLU TEPE N, Ozcorekci O
Knowledge about the human papillomavirus among high school and university students a comprehensive questionnaire study from Southeast Turkey.
J Obstet Gynaecol Res. 2020;46:907-916.
PubMed
Abstract available

SONG YC, Huang HC, Chang CY, Lee HJ, et al
A Potential Herbal Adjuvant Combined With a Peptide-Based Vaccine Acts Against HPV-Related Tumors Through Enhancing Effector and Memory T-Cell Immune Responses.
Front Immunol. 2020;11:62.
PubMed
Abstract available

MEHRA N, Christopher V, Dhanushkodi M, Radhakrishnan V, et al
A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin.
Int J Clin Pharm. 2020;42:662-666.
PubMed
Abstract available

SHYAMSIVAPPAN S, Vivek R, Saravanan A, Arasakumar T, et al
A novel 8-nitro quinoline-thiosemicarbazone analogues induces G1/S & G2/M phase cell cycle arrest and apoptosis through ROS mediated mitochondrial pathway.
Bioorg Chem. 2020;97:103709.
PubMed
Abstract available

OZCAN Z, Kimiloglu E, Igdem AA, Erdogan N, et al
Comparison of the Diagnostic Utility of Manual Screening and the ThinPrep Imaging System in Liquid-Based Cervical Cytology.
Turk Patoloji Derg. 2020;36:135-141.
PubMed
Abstract available

YUE Z, Ding S, Zhao W, Wang H, et al
Automatic CIN Grades Prediction of Sequential Cervigram Image Using LSTM With Multistate CNN Features.
IEEE J Biomed Health Inform. 2020;24:844-854.
PubMed
Abstract available

DU J, Song D, Li J, Li Y, et al
Paeonol triggers apoptosis in HeLa cervical cancer cells: the role of mitochondria-related caspase pathway.
Psychopharmacology (Berl). 2021 Mar 12. pii: 10.1007/s00213-021-05811.
PubMed
Abstract available

LI R, Zhang Y, Ma B, Tan K, et al
Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.
Ann Transl Med. 2021;9:239.
PubMed
Abstract available

FARZANEHPOUR M, Faghihloo E, Salimi V, Jalilvand S, et al
Comparison of Snail1, ZEB1, E-Cadherin Expression Levels in HPV-Induced Cervical Cancer.
Iran J Public Health. 2020;49:2179-2188.
PubMed
Abstract available

JIANG L, Li B, Zhang Y, Ma S, et al
Influence of Pelvic Intensity-Modulated Radiation Therapy With Concurrent Cisplatin-Based Chemotherapy of Cervical Cancer on the Vaginal Microbiome.
Front Oncol. 2021;11:615439.
PubMed
Abstract available

CASTELLI S, Ciccarone F, Tavian D, Ciriolo MR, et al
ROS-dependent HIF1alpha activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells.
J Exp Clin Cancer Res. 2021;40:94.
PubMed
Abstract available

ZIVARPOUR P, Nikkhah E, Maleki Dana P, Asemi Z, et al
Molecular and biological functions of gingerol as a natural effective therapeutic drug for cervical cancer.
J Ovarian Res. 2021;14:43.
PubMed
Abstract available

MWALIKO E, Van Hal G, Bastiaens H, Van Dongen S, et al
Early detection of cervical cancer in western Kenya: determinants of healthcare providers performing a gynaecological examination for abnormal vaginal discharge or bleeding.
BMC Fam Pract. 2021;22:52.
PubMed
Abstract available

SHRIVASTAVA A, Mishra SP, Pradhan S, Choudhary S, et al
An Assessment of Serum Oxidative Stress and Antioxidant Parameters in Patients Undergoing Treatment for Cervical Cancer.
Free Radic Biol Med. 2021 Mar 8. pii: S0891-5849(21)00135.
PubMed
Abstract available

WANG Y, Shen N, Li S, Yu H, et al
Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis.
Nano Lett. 2021 Mar 11. doi: 10.1021/acs.nanolett.0c04402.
PubMed
Abstract available

WANG Y, He M, Zhang G, Cao K, et al
The immune landscape during the tumorigenesis of cervical cancer.
Cancer Med. 2021 Mar 10. doi: 10.1002/cam4.3833.
PubMed
Abstract available

SALAVATIHA Z, Farahmand M, Shoja Z, Jalilvand S, et al
A meta-analysis of human papillomavirus prevalence and types among Iranian women with normal cervical cytology, premalignant lesions, and cervical cancer.
J Med Virol. 2021 Mar 10. doi: 10.1002/jmv.26928.
PubMed
Abstract available

LIU X, Feng Q, Zhang Y, Zheng P, et al
Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial-mesenchymal transition.
Cancer Cell Int. 2021;21:163.
PubMed
Abstract available

AHMAD A, Tiwari RK, Saeed M, Ahmad I, et al
Glycyrrhizin Mediates Downregulation of Notch Pathway Resulting in Initiation of Apoptosis and Disruption in the Cell Cycle Progression in Cervical Cancer Cells.
Nutr Cancer. 2021 Mar 10:1-18. doi: 10.1080/01635581.2021.1895234.
PubMed
Abstract available

HARUYAMA R, Obara H, Fujita N
What is the current status of Japan's efforts to meet global goals and targets to eliminate cervical cancer?
Glob Health Med. 2021;3:44-47.
PubMed
Abstract available

CHA EY, Chun H
Barriers and Challenges to Cervical Cancer Screening, Follow-Up, and Prevention Measures among Korean Immigrant Women in Hawaii.
Asia Pac J Oncol Nurs. 2021;8:132-138.
PubMed
Abstract available

DUAN Y, Bai H, Li X, Wang D, et al
Oncolytic adenoviral H101 synergizes with radiation in cervical cancer cells.
Curr Cancer Drug Targets. 2021 Mar 7. pii: CCDT-EPUB-114753.
PubMed
Abstract available

ZHAO J, Li H, Yuan M
EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
Genes Genomics. 2021 Mar 9. pii: 10.1007/s13258-021-01064.
PubMed
Abstract available

KUEHN BM
Dramatic Cervical Cancer Screening Decline During Pandemic.
JAMA. 2021;325:925.
PubMed

BUDAK A, Budak E, Kanmaz AG, Inan AH, et al
Volumetric PET parameters are predictive for the prognosis of locally advanced cervical cancer.
Q J Nucl Med Mol Imaging. 2021 Mar 9. pii: S1824-4785.21.03324.
PubMed
Abstract available

MAO D, Cao H, Shi M, Wang CC, et al
Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
EBioMedicine. 2021;65:103242.
PubMed
Abstract available

WANG J, Zhang C
Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer.
Bioengineered. 2021;12:898-913.
PubMed
Abstract available

CAO X, Che X
The effect of different doses of Dexmetomidine anesthesia on the recovery time of laparoscopic surgery for cervical cancer.
Minerva Med. 2021 Mar 8. pii: S0026-4806.21.07344.
PubMed

FAVRE G, Guani B, Balaya V, Magaud L, et al
Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial.
Front Oncol. 2021;10:621518.
PubMed
Abstract available

QU HD, Han DM, Zhang N, Mao Z, et al
Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
Front Oncol. 2021;10:621347.
PubMed
Abstract available

XING B, Guo J, Sheng Y, Wu G, et al
Human Papillomavirus-Negative Cervical Cancer: A Comprehensive Review.
Front Oncol. 2021;10:606335.
PubMed
Abstract available

BRAVO-CUELLAR A, Ortiz-Lazareno PC, Sierra-Diaz E, Solorzano-Ibarra F, et al
Pentoxifylline Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment: Involvement of Mitochondrial and NF-Kappa B Pathways.
Front Oncol. 2020;10:592706.
PubMed
Abstract available

AITKEN CA, Kaljouw S, Siebers AG, Bron M, et al
sInvestigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics.
Prev Med Rep. 2021;22:101328.
PubMed
Abstract available

SONODA K, Ohgami T, Hachisuga M, Fujita Y, et al
Difficulty of cervical cancer diagnosis during pregnancy: A case series analysis of the clinicopathological characteristics and prognosis of cervical cancer diagnosed during pregnancy or within 6 months after parturition.
Mol Clin Oncol. 2021;14:67.
PubMed
Abstract available

MOODLEY J, Constant D, Mwaka AD, Scott SE, et al
Anticipated help seeking behaviour and barriers to seeking care for possible breast and cervical cancer symptoms in Uganda and South Africa.
Ecancermedicalscience. 2021;15:1171.
PubMed
Abstract available

SHI X, Deng Z, Wang S, Zhao S, et al
Increased HSF1 Promotes Infiltration and Metastasis in Cervical Cancer via Enhancing MTDH-VEGF-C Expression.
Onco Targets Ther. 2021;14:1305-1315.
PubMed
Abstract available

WANG T, Zhang XD, Hua KQ
A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
Taiwan J Obstet Gynecol. 2021;60:253-261.
PubMed
Abstract available

PORTNOY A, Pedersen K, Trogstad L, Hansen BT, et al
Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis.
Prev Med. 2021;144:106276.
PubMed
Abstract available

CAMPOS NG, Demarco M, Bruni L, Desai KT, et al
A proposed new generation of evidence-based microsimulation models to inform global control of cervical cancer.
Prev Med. 2021;144:106438.
PubMed
Abstract available

OLIVEIRA CR, Niccolai LM
Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination.
Prev Med. 2021;144:106363.
PubMed
Abstract available

ORTIZ AP, Soto-Salgado M, Calo WA, Hull P, et al
Elimination of cervical cancer in U.S. Hispanic populations: Puerto Rico as a case study.
Prev Med. 2021;144:106336.
PubMed
Abstract available

HINMAN AR, Orenstein WA
Elimination of cervical cancer: Lessons learned from polio and earlier eradication programs.
Prev Med. 2021;144:106325.
PubMed
Abstract available

GRAVITT PE, Silver MI, Hussey HM, Arrossi S, et al
Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach.
Prev Med. 2021;144:106322.
PubMed
Abstract available

WHOP LJ, Smith MA, Butler TL, Adcock A, et al
Achieving cervical cancer elimination among Indigenous women.
Prev Med. 2021;144:106314.
PubMed
Abstract available

TORODE J, Kithaka B, Chowdhury R, Simelela N, et al
National action towards a world free of cervical cancer for all women.
Prev Med. 2021;144:106313.
PubMed

GODFREY C, Prainito A, Lapidos-Salaiz I, Barnhart M, et al
Reducing cervical cancer deaths in women living with HIV: PEPFAR and the Go Further partnership.
Prev Med. 2021;144:106295.
PubMed
Abstract available

GIULIANO AR, Niccolai LM
A world without cervical cancer is within our reach.
Prev Med. 2021;144:106462.
PubMed

PINEROS M, Saraiya M, Baussano I, Bonjour M, et al
The role and utility of population-based cancer registries in cervical cancer surveillance and control.
Prev Med. 2021;144:106237.
PubMed
Abstract available

CARRERO YN, Callejas DE, Mosquera JA
In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review.
Transl Oncol. 2021;14:101058.
PubMed
Abstract available

WAN HY, Li QQ, Zhang Y, Tian W, et al
Corrigendum to "MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells" [Cancer Letters 355 (2014) 148-158].
Cancer Lett. 2021 Mar 3. pii: S0304-3835(21)00087.
PubMed

LIU YY, Guo RX, Li BJ, Wu Y, et al
[Analysis of clinical features of cervical precancerous lesions in postmenopausal women].
Zhonghua Fu Chan Ke Za Zhi. 2021;56:114-120.
PubMed
Abstract available

WANG Z, Kang Y, Yu F, Zhong FH, et al
TruScreen detection of cervical tissues for high-risk human papillomavirus-infected women during the COVID-19 pandemic.
Future Oncol. 2021;17:1197-1207.
PubMed
Abstract available

IEZZONI LI, Rao SR, Agaronnik ND, El-Jawahri A, et al
Associations Between Disability and Breast or Cervical Cancers, Accounting for Screening Disparities.
Med Care. 2021;59:139-147.
PubMed
Abstract available

SONG M, Lin J, Song F, Wu D, et al
The value of MR-based radiomics in identifying residual disease in patients with carcinoma in situ after cervical conization.
Sci Rep. 2020;10:19890.
PubMed
Abstract available

REHEMAN D, Zhao J, Guan S, Xu GC, et al
Apoptotic effect of novel pyrazolone-based derivative [Cu(PMPP-SAL)(EtOH)] on HeLa cells and its mechanism.
Sci Rep. 2020;10:18235.
PubMed
Abstract available

XU J, Zou J, Wu L, Lu W, et al
Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma.
Sci Rep. 2020;10:16584.
PubMed
Abstract available

ASIEDU MN, Agudogo JS, Dotson ME, Skerrett E, et al
A novel speculum-free imaging strategy for visualization of the internal female lower reproductive system.
Sci Rep. 2020;10:16570.
PubMed
Abstract available

WU Y, Wang X, Meng L, Li W, et al
Changes of miRNA Expression Profiles from Cervical-Vaginal Fluid-Derived Exosomes in Response to HPV16 Infection.
Biomed Res Int. 2020;2020:7046894.
PubMed
Abstract available

BARQUET-MUNOZ SA, Cantu-de-Leon D, Bandala-Jacques A, Gonzalez-Enciso A, et al
What is the impact of radical hysterectomy on endometrial cancer with cervical involvement?
World J Surg Oncol. 2020;18:101.
PubMed
Abstract available

ROSENDO-CHALMA P, Antonio-Vejar V, Bigoni-Ordonez GD, Patino-Morales CC, et al
CDH1 and SNAI1 are regulated by E7 from human papillomavirus types 16 and 18.
Int J Oncol. 2020;57:301-313.
PubMed
Abstract available

ZHANG X, Liu CR, Wang ZZ, Ren ZF, et al
Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study.
Vaccine. 2020;38:3665-3670.
PubMed
Abstract available

BAE JK, Roh HJ, You JS, Kim K, et al
Quantitative Screening of Cervical Cancers for Low-Resource Settings: Pilot Study of Smartphone-Based Endoscopic Visual Inspection After Acetic Acid Using Machine Learning Techniques.
JMIR Mhealth Uhealth. 2020;8:e16467.
PubMed
Abstract available

LERAY H, Gabiache E, Courbon F, Brenot-Rossi I, et al
FDG-PET/CT identifies predictors of survival in patients with locally advanced cervical carcinoma and para-aortic lymph node involvement to increase treatment.
J Nucl Med. 2020 Feb 7. pii: jnumed.119.238824. doi: 10.2967/jnumed.119.238824.
PubMed
Abstract available

WANG J, Zhu Z, Qiu H, Liu C, et al
LncRNA NKILA inhibits the proliferation and promotes the apoptosis of CSCC cells by downregulating miRNA-21.
J Cell Physiol. 2020;235:7863-7869.
PubMed
Abstract available

ANWARI P, Debellut F, Vodicka E, Clark A, et al
Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan.
Vaccine. 2019 Dec 20. pii: S0264-410X(19)31655.
PubMed
Abstract available

ZHAO J, Zhu J, Guo J, Zhu T, et al
Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women.
J Med Virol. 2020;92:372-381.
PubMed
Abstract available

KAZAN HH, Urfali-Mamatoglu C, Yalcin GD, Bulut O, et al
15-LOX-1 has diverse roles in the resensitization of resistant cancer cell lines to doxorubicin.
J Cell Physiol. 2020;235:4965-4978.
PubMed
Abstract available

ZHANG S, Saito M, Yamada S, Sakamoto J, et al
The prevalence of VAIN, CIN, and related HPV genotypes in Japanese women with abnormal cytology.
J Med Virol. 2020;92:364-371.
PubMed
Abstract available

PESIC A, Krings A, Hempel M, Preyer R, et al
Clinical performance of the HPV DNA Array genotyping assay in detection of CIN2+ lesions with BS GP5+/6+ MPG Luminex tested cervical samples.
J Med Virol. 2020;92:113-118.
PubMed
Abstract available

LV F, Zhong Y, Sang L, Wu X, et al
MiR-1179 is downregulated in cervical cancer and its overexpression suppresses cancer cells invasion by targeting CHAF1A/ZEB1.
Acta Biochim Pol. 2021 Mar 19. pii: 5499. doi: 10.18388/abp.2020_5499.
PubMed
Abstract available

KIMONDO FC, Kajoka HD, Mwantake MR, Amour C, et al
Knowledge, attitude, and practice of cervical cancer screening among women living with HIV in the Kilimanjaro region, northern Tanzania.
Cancer Rep (Hoboken). 2021 Mar 19:e1374. doi: 10.1002/cnr2.1374.
PubMed
Abstract available

JANKOVIC S, Zivkovic Zaric R, Krasic K, Opancina V, et al
New instrument for measuring quality of life in patients with cervical cancer.
Health Care Women Int. 2021 Mar 19:1-15. doi: 10.1080/07399332.2021.1878174.
PubMed
Abstract available

YANG Y, Han A, Wang X, Yin X, et al
Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis.
J Cell Mol Med. 2021 Mar 18. doi: 10.1111/jcmm.16461.
PubMed
Abstract available

GRAVDAL BH, Lonnberg S, Skare GB, Sulo G, et al
Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.
BMC Womens Health. 2021;21:110.
PubMed
Abstract available

WANG Z, Ren C, Yang L, Zhang X, et al
Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of CDK4.
Aging (Albany NY). 2021;13.
PubMed
Abstract available

GU Q, Hou W, Shi L, Liu H, et al
Circular RNA ZNF609 functions as a competing endogenous RNA in regulating E2F transcription factor 6 through competitively binding to microRNA-197-3p to promote the progression of cervical cancer progression.
Bioengineered. 2021;12:927-936.
PubMed
Abstract available

VENGALOOR THOMAS T, Gandhi S, Bhanat E, Krishna K, et al
An Analysis of the Racial Disparities Among Cervical Cancer Patients Treated at an Academic Medical Center in the Southeastern United States.
Cureus. 2021;13:e13296.
PubMed
Abstract available

LIANG LJ, Yang Y, Wei WF, Wu XG, et al
Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression.
Oncogenesis. 2021;10:30.
PubMed
Abstract available

XU S, Wang X, Yang Y, Li Y, et al
LSD1 silencing contributes to enhanced efficacy of anti-CD47/PD-L1 immunotherapy in cervical cancer.
Cell Death Dis. 2021;12:282.
PubMed
Abstract available

BURGER EA, Jansen EE, Killen J, Kok IM, et al
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States.
J Med Screen. 2021 Mar 17:9691413211001097. doi: 10.1177/09691413211001097.
PubMed
Abstract available

CHEN W
[New research progress of the safety of human papillomavirus vaccine].
Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55:428-434.
PubMed
Abstract available

SUN W, Li J, Yang ZY, Zheng YD, et al
[The research progress of circular RNAs in the development and progression of cervical cancer].
Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55:409-412.
PubMed
Abstract available

CHIVA L, Chacon E
Is Conization a Protective Surgical Maneuver in Early Cervical Cancer?
Ann Surg Oncol. 2021 Mar 17. pii: 10.1245/s10434-021-09705.
PubMed

HOLMSTROM O, Linder N, Kaingu H, Mbuuko N, et al
Point-of-Care Digital Cytology With Artificial Intelligence for Cervical Cancer Screening in a Resource-Limited Setting.
JAMA Netw Open. 2021;4:e211740.
PubMed
Abstract available

SONG TF, Xu AL, Chen XH, Gao JY, et al
Circular RNA circRNA_101996 promoted cervical cancer development by regulating miR-1236-3p/TRIM37 axis.
Kaohsiung J Med Sci. 2021 Mar 17. doi: 10.1002/kjm2.12378.
PubMed
Abstract available

CHEN Z, Ling K, Zhu Y, Deng L, et al
circ0000069 promotes cervical cancer cell proliferation and migration by inhibiting miR-4426.
Biochem Biophys Res Commun. 2021;551:114-120.
PubMed
Abstract available

MARIE TEBEU P, Saint Saba Antaon J, Adjeba M, Pikop F, et al
[Knowledge, attitudes and practices of health professionals regard to cervical cancer in Cameroon].
Sante Publique. 2020;32:489-496.
PubMed
Abstract available

GONG SJ, Shim SJ
Successful treatment results of external radiotherapy without brachytherapy in advanced uterine cervical cancer.
J Cancer Res Ther. 2021;17:255-257.
PubMed
Abstract available

KUMAR A, Tudu R, Singh R, Raina P, et al
Dose-volume analysis of acute gastrointestinal complications in cervical cancer undergoing definitive concurrent chemoradiation.
J Cancer Res Ther. 2021;17:170-173.
PubMed
Abstract available

TIAN T, Dong Y, Zhu Y, Chen Y, et al
Hypoxia-induced CNPY2 upregulation promotes glycolysis in cervical cancer through activation of AKT pathway.
Biochem Biophys Res Commun. 2021;551:63-70.
PubMed
Abstract available

YU EY, Zhao RY, Wang DS
Inhibitory effect of Aphidicolin - a tetracyclic diterpene - on the proliferation and apoptotic induction in human cervical cancer (HeLa) cells.
J BUON. 2021;26:291.
PubMed
Abstract available

CHEN H, Feng X, Gao L, Mickymaray S, et al
Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: attenuating the proliferation of cervical cancer cells.
Artif Cells Nanomed Biotechnol. 2021;49:240-249.
PubMed
Abstract available

KOVACHEV SM, Kovachev MS
The role of perioperative ureteral stenting for urologic complications in radical surgery of cervical cancer.
Urologia. 2021 Mar 14:3915603211001178. doi: 10.1177/03915603211001178.
PubMed
Abstract available

YOUNES S, Kaufmann AM, Hafner N, Beer K, et al
Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer.
Cancer Rep (Hoboken). 2021 Mar 14:e1366. doi: 10.1002/cnr2.1366.
PubMed
Abstract available

LEI C, Huang M, Li N, An J, et al
Intensity-modulated radiotherapy combined with intracavitary brachytherapy for locally advanced cervical cancer with uterus didelphys.
Gynecol Oncol Rep. 2021;36:100724.
PubMed
Abstract available

HUANG Y, Tian Y, Zhang W, Liu R, et al
Rab12 Promotes Radioresistance of HPV-Positive Cervical Cancer Cells by Increasing G2/M Arrest.
Front Oncol. 2021;11:586771.
PubMed
Abstract available

TAWE L, Grover S, Zetola N, Robertson ES, et al
Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana.
Front Oncol. 2021;11:560296.
PubMed
Abstract available

WANG A, Xu Q, Sha R, Bao T, et al
MicroRNA-29a inhibits cell proliferation and arrests cell cycle by modulating p16 methylation in cervical cancer.
Oncol Lett. 2021;21:272.
PubMed
Abstract available

LAIOS A, Duarte Portela S, Papadopoulou A, Gallos ID, et al
Ovarian transposition and cervical cancer.
Best Pract Res Clin Obstet Gynaecol. 2021 Feb 26. pii: S1521-6934(21)00037.
PubMed
Abstract available

AKGUN AKTAS B, Toptas T, Ureyen I, Dogan S, et al
Obstetrician-gynecologists' practice patterns regarding HPV testing in cervical cancer screening in Turkey.
Turk J Obstet Gynecol. 2021;18:15-22.
PubMed
Abstract available

AFFAR S, Morrison DS, Campbell C
Cervical cancer incidence by ethnic group in Scotland from 2008 to 2017: A population-based study.
Eur J Cancer Care (Engl). 2021 Mar 14:e13441. doi: 10.1111/ecc.13441.
PubMed
Abstract available

MISHRA N, Mishra S
Exendin-4 - A potential therapeutic for type 2 diabetes-linked cervical cancer?
EBioMedicine. 2021;65:103273.
PubMed

AZAR D, Murphy M, Fishman A, Sewell L, et al
Barriers and facilitators to participation in breast, bowel and cervical cancer screening in rural Victoria: a qualitative study.
Health Promot J Austr. 2021 Mar 13. doi: 10.1002.
PubMed
Abstract available

LEE J, Lin JB, Wu MH, Chang CL, et al
Association of bowel radiation dose-volume with skeletal muscle loss during pelvic intensity-modulated radiotherapy in cervical cancer.
Support Care Cancer. 2021 Mar 12. pii: 10.1007/s00520-021-06131.
PubMed
Abstract available

NI M, Li J, Zhao H, Xu F, et al
BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair.
Oncogene. 2021 Mar 12. pii: 10.1038/s41388-021-01735.
PubMed
Abstract available

SIMJAK P, Parizek A, Slama J
Prenatal care for woman after fertility-sparing surgery for cervical cancer.
Ceska Gynekol. 2020;85:422-429.
PubMed
Abstract available

SLAMA J, Dvorak V, Trnkova M, Skrivanek A, et al
Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
Ceska Gynekol. 2020;85:368-374.
PubMed
Abstract available

KASAVEN LS, Jones BP, Keays R, Saso S, et al
Anaesthetic considerations for fertility-sparing surgery and uterine transplantation.
Anaesthesia. 2021;76 Suppl 4:46-55.
PubMed
Abstract available

WOO YL, Gravitt P, Khor SK, Ng CW, et al
Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era.
Prev Med. 2021;144:106294.
PubMed
Abstract available

MOTAZE NV, Chi PC, Ongolo-Zogo P, Ndongo JS, et al
Government regulation of private health insurance.
Cochrane Database Syst Rev. 2021;2:CD011512.
PubMed
Abstract available

SMOLARCZYK K, Pieta W, Majewski S
Assessment of the State of Knowledge about HPV Infection and HPV Vaccination among Polish Resident Doctors.
Int J Environ Res Public Health. 2021;18.
PubMed
Abstract available

DU J, Ahrlund-Richter A, Nasman A, Dalianis T, et al
Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008-2018, and perspectives on cancer prevention.
Arch Gynecol Obstet. 2021;303:329-335.
PubMed
Abstract available

MAJOR AL, Dvorak V, Schwarzova J, Skrivanek A, et al
Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial.
Arch Gynecol Obstet. 2021;303:501-511.
PubMed
Abstract available

NASIOUDIS D, Albright B, Haggerty AF, Ko EM, et al
Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size less than or equal to 2 cm.
Am J Obstet Gynecol. 2020 Oct 28. pii: S0002-9378(20)31274.
PubMed

LONG T, Long L, Chen Y, Li Y, et al
Severe cervical inflammation and high-grade squamous intraepithelial lesions: a cross-sectional study.
Arch Gynecol Obstet. 2021;303:547-556.
PubMed
Abstract available

INKMAN MJ, Jayachandran K, Ellis TM, Ruiz F, et al
HPV-EM: an accurate HPV detection and genotyping EM algorithm.
Sci Rep. 2020;10:14340.
PubMed
Abstract available

FU Y, Wang X, Lu W
A Question to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
J Low Genit Tract Dis. 2020;24:425.
PubMed

LI J, Peng K, Li Y, Wang J, et al
Exosome-Mimetic Supramolecular Vesicles with Reversible and Controllable Fusion and Fission*.
Angew Chem Int Ed Engl. 2020;59:21510-21514.
PubMed
Abstract available

LIN M, Zhang Q, Song Y, Yu X, et al
Differentiation of endometrial adenocarcinoma from adenocarcinoma of cervix using kinetic parameters derived from DCE-MRI.
Eur J Radiol. 2020;130:109190.
PubMed
Abstract available

HALLAM N, Parker J
HPV Catch-up Vaccination Reduces the Prevalence of HPV 16 and 18 Infections and Cervical Disease: A Retrospective Study.
J Low Genit Tract Dis. 2020;24:421.
PubMed

MANDAL R, Ghosh I, Banerjee D, Mittal S, et al
Correlation Between p16/Ki-67 Expression and the Grade of Cervical Intraepithelial Neoplasias.
Int J Gynecol Pathol. 2020;39:384-390.
PubMed
Abstract available

YORITA K, Hirano K, Kai Y, Tanaka Y, et al
White Adipocytes of the Uterine Cervix Tend to Appear in Women of Older Age, Postmenopause Status, and Higher Body Mass Index.
Int J Gynecol Pathol. 2020;39:379-383.
PubMed
Abstract available

Update on the ISGyP Endocervical Adenocarcinoma Project.
Int J Gynecol Pathol. 2020;39:1.
PubMed

AOKI T, Fukuhara S
Associations of types of primary care facilities with adult vaccination and cancer screening in Japan.
Int J Qual Health Care. 2020;32:373-378.
PubMed
Abstract available

SCARINCI IC, Hansen B, Kim YI
HPV vaccine uptake among daughters of Latinx immigrant mothers: Findings from a cluster randomized controlled trial of a community-based, culturally relevant intervention.
Vaccine. 2020 Apr 27. pii: S0264-410X(20)30441.
PubMed
Abstract available

SCHIFFMAN M, Wentzensen N, Perkins RB, Guido RS, et al
An Introduction to the 2019 ASCCP Risk-Based Management Consensus Guidelines.
J Low Genit Tract Dis. 2020;24:87-89.
PubMed

HOOD RB, Turner AN, Huber-Krum S, Lancaster KE, et al
For Human Papillomavirus Self-Sampling, Stated Willingness Does Not Correspond With Subsequent Uptake by Rural Malawian Women.
Sex Transm Dis. 2020;47:275-279.
PubMed
Abstract available

LAN L, Liang Z, Zhao Y, Mo Y, et al
LncRNA MCM3AP-AS1 inhibits cell proliferation in cervical squamous cell carcinoma by down-regulating miRNA-93.
Biosci Rep. 2020;40.
PubMed
Abstract available

DURMUS Y, Karalok A, Basaran D, Kamani MO, et al
Can we predict surgical margin positivity while performing cervical excisional procedures?
J Obstet Gynaecol. 2020;40:666-672.
PubMed
Abstract available

PECOURT M, Gondry J, Foulon A, Lanta-Delmas S, et al
Value of large loop excision of the transformation zone (LLETZ) without histological proof of high-grade cervical intraepithelial lesion: Results of a two-year continuous retrospective study.
J Gynecol Obstet Hum Reprod. 2020;49:101621.
PubMed
Abstract available

LIU Y, Di N, Tao X
Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China.
Hum Vaccin Immunother. 2020;16:116-123.
PubMed
Abstract available

WANG Y, Yao Y, Dou Y, Tang S, et al
Chopstick technique used in laparoendoscopic single site radical hysterectomy for early stage cervical cancer.
Sci Rep. 2021;11:6882.
PubMed
Abstract available

EJEGOD DM, Pedersen H, Quint W, Xu L, et al
Clinical and analytical performance of the CLART HPV 4S assay with SurePath screening samples from the Danish cervical cancer screening program using the VALGENT framework.
J Virol Methods. 2021 Mar 22:114118. doi: 10.1016/j.jviromet.2021.114118.
PubMed
Abstract available

YUAN T, Sun J, Tian J, Hu J, et al
Involvement of ABC transporters in the detoxification of non-substrate nanoparticles in lung and cervical cancer cells.
Toxicology. 2021 Mar 22:152762. doi: 10.1016/j.tox.2021.152762.
PubMed
Abstract available

ZHANG L, Wu ZA
MicroRNA-378a-3p Downregulation as a Novel Biomarker with Poor Clinical Outcomes in Cervical Cancer.
Biomed Environ Sci. 2021;34:213-221.
PubMed
Abstract available

CHEN Q, Qiu B, Zeng X, Hu L, et al
Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis.
Cancer Cell Int. 2021;21:182.
PubMed
Abstract available

POLJAK M, Cuschieri K, Waheed DE, Baay M, et al
Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening.
Acta Dermatovenerol Alp Pannonica Adriat. 2021;30:21-26.
PubMed
Abstract available

KILIC C, Kimyon Comert G, Cakir C, Yuksel D, et al
Recurrence pattern and prognostic factors for survival in cervical cancer with lymph node metastasis.
J Obstet Gynaecol Res. 2021 Mar 25. doi: 10.1111/jog.14762.
PubMed
Abstract available

BORGER TN, Puleo GE, Rivera Rivera JN, Montgomery D, et al
A descriptive study of cervical cancer survivors' persistent smoking behavior and perceived barriers to quitting.
Psychol Addict Behav. 2021 Mar 25. pii: 2021-28515-001. doi: 10.1037/adb0000692.
PubMed
Abstract available

WANG Q, Zheng W
Upregulation of CDC7 Associated with Cervical Cancer Incidence and Development.
Biomed Res Int. 2021;2021:6663367.
PubMed
Abstract available

SALCEDO MP, Varon ML, Phoolcharoen N, Osman N, et al
Building local capacity for cervical cancer prevention in low resource settings: Changing strategy during the COVID-19 pandemic.
J Glob Health. 2021;11:03044.
PubMed

LI W, Ping Z, Xuemei G, Minglian L, et al
Retracted: Naturally Occurring Sclareol Diterpene Augments the Chemosensitivity of Human Hela Cervical Cancer Cells by Inducing Mitochondrial Mediated Programmed Cell Death, S-Phase Cell Cycle Arrest and Targeting Mitogen-Activated Protein Kinase (MAP
Med Sci Monit. 2021;27:e932350.
PubMed
Abstract available

JIANG L, Shi S, Li F, Shi Q, et al
miR519d3p/HIF2alpha axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
Mol Med Rep. 2021;23.
PubMed
Abstract available

SHARMA A, Biswas B, Sati B
Attributes of screening and vaccination for cervical cancer: insights of an online survey among female school teachers of Kota, Rajasthan, India.
Health Promot Perspect. 2021;11:45-53.
PubMed
Abstract available

LIU X, Zhang Y, Zheng P, Cui N, et al
Msi1 inhibits cervical cancer cell apoptosis by downregulating BAK through AKT signaling.
J Cancer. 2021;12:2422-2429.
PubMed
Abstract available

HSIAO YH, Yang SF, Chen YH, Chen TH, et al
Updated applications of Ultrasound in Uterine Cervical Cancer.
J Cancer. 2021;12:2181-2189.
PubMed
Abstract available

KIRUBARAJAN A, Leung S, Li X, Yau M, et al
Barriers and facilitators for cervical cancer screening among adolescents and young people: a systematic review.
BMC Womens Health. 2021;21:122.
PubMed
Abstract available

ZHU L, Huang Y, Lam D, Gach HM, et al
Targetability of cervical cancer by magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU)-mediated hyperthermia (HT) for patients receiving radiation therapy.
Int J Hyperthermia. 2021;38:498-510.
PubMed
Abstract available

BA DM, Ssentongo P, Musa J, Agbese E, et al
Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study.
Cancer Epidemiol. 2021;72:101930.
PubMed
Abstract available

ROSENBERG K
Transmission of Cervical Cancer from Mother to Child.
Am J Nurs. 2021;121:48.
PubMed
Abstract available

JABLONSKA E, Li Q, Reszka E, Wieczorek E, et al
Therapeutic Potential of Selenium and Selenium Compounds in Cervical Cancer.
Cancer Control. 2021;28:10732748211001808.
PubMed
Abstract available

PIYATHILAKE CJ, Kumar R, Crowley MR, Badiga S, et al
Human papillomavirus sequencing reveals its usefulness for the management of HIV-infected women at risk for developing cervical cancer.
J Obstet Gynaecol Res. 2021 Mar 23. doi: 10.1111/jog.14754.
PubMed
Abstract available

KRISHNAMOORTHY Y, Ganesh K, Sakthivel M
Prevalence and determinants of breast and cervical cancer screening among women aged between 30 and 49 years in India: Secondary data analysis of National Family Health Survey - 4.
Indian J Cancer. 2021 Jan 27. pii: 308044. doi: 10.4103.
PubMed
Abstract available

KASIUS JC, van der Velden J, Denswil NP, Tromp JM, et al
Neo-adjuvant chemotherapy in fertility-sparing cervical cancer treatment.
Best Pract Res Clin Obstet Gynaecol. 2021 Feb 20. pii: S1521-6934(21)00019.
PubMed
Abstract available

WANG M, Gu H, Hu J, Liang J, et al
Evaluation of a highly refined prediction model in knowledge-based volumetric modulated arc therapy planning for cervical cancer.
Radiat Oncol. 2021;16:58.
PubMed
Abstract available

M M, V D, J H, D S, et al
Serum concentrations of S100-A11 and AIF-1 are elevated in cervical cancer patients with lymph node involvement.
Ceska Gynekol. 2021;86:17-21.
PubMed
Abstract available

M M, V D, J H, D S, et al
Elevated serum concentrations of S100-A11 and AIF-1 in cervical dysplasia patients.
Ceska Gynekol. 2021;86:11-15.
PubMed
Abstract available

HOU YX, Min CL, Ma LJ
miR-520 predicates poor prognosis and inhibits the progression of cervical cancer.
J Biol Regul Homeost Agents. 2021;35.
PubMed

YONEOKA Y, Kato MK, Tanase Y, Uno M, et al
The baseline recurrence risk of patients with intermediate-risk cervical cancer.
Obstet Gynecol Sci. 2021;64:226-233.
PubMed
Abstract available

JACH R, Mazurec M, Trzeszcz M, Zimmer M, et al
Cervical cancer screening in Poland in current SARS-CoV-2 pandemic: Interim guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology - a summary January 2021.
Ginekol Pol. 2021;92:165-173.
PubMed
Abstract available

BALLARI N, Rai B, Bahl A, Mittal BR, et al
Prospective observational study evaluating acute and delayed treatment related toxicities of prophylactic extended field volumetric modulated arc therapy with concurrent cisplatin in cervical cancer patients with pelvic lymph node metastasis.
Tech Innov Patient Support Radiat Oncol. 2021;17:48-56.
PubMed
Abstract available

TIAN P, Zhang C, Ma C, Ding L, et al
Decreased chromobox homologue 7 expression is associated with epithelial-mesenchymal transition and poor prognosis in cervical cancer.
Open Med (Wars). 2021;16:410-418.
PubMed
Abstract available

YAO S, Sun H
Expression and Clinical Significance of CREPT and CDK4 in Cervical Cancer.
Iran J Public Health. 2021;50:418-420.
PubMed

BAYDOUN A, Xu KE, Heo JU, Yang H, et al
Synthetic CT Generation of the Pelvis in Patients With Cervical Cancer: A Single Input Approach Using Generative Adversarial Network.
IEEE Access. 2021;9:17208-17221.
PubMed
Abstract available

FAN Q, Huang T, Sun X, Yang X, et al
miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor alpha and androgen receptor in cervical cancer.
Exp Ther Med. 2021;21:414.
PubMed
Abstract available

RASI BONAB F, Baghbanzadeh A, Ghaseminia M, Bolandi N, et al
Molecular pathways in the development of HPV-induced cervical cancer.
EXCLI J. 2021;20:320-337.
PubMed
Abstract available

KATANYOO K, Thavorncharoensap M, Chaikledkaew U, Riewpaiboon A, et al
A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer.
Expert Rev Pharmacoecon Outcomes Res. 2021.
PubMed
Abstract available

SONG J, Lu Y, Wang X, Peng W, et al
A comparative study of four diffusion-weighted imaging models in the diagnosis of cervical cancer.
Acta Radiol. 2021 Mar 20:2841851211002017. doi: 10.1177/02841851211002017.
PubMed
Abstract available

PHUA LC, Choi HCW, Wu J, Jit M, et al
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore.
Vaccine. 2021 Mar 17. pii: S0264-410X(21)00321.
PubMed
Abstract available

CAI J, He X, Wang H, Dong W, et al
Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes.
Radiat Oncol. 2021;16:54.
PubMed
Abstract available

DADAK A, Ouyaba AT
Developing the Attitude Scale for Protection From Cervical Cancer.
J Nurs Meas. 2021 Mar 19. pii: JNM-D-19-00081. doi: 10.1891/JNM-D-19-00081.
PubMed
Abstract available

SMALL W JR, Kim YS, Joyce C, Surucu M, et al
Uterine perforation during brachytherapy for cervical cancer: Complications, outcomes, and best practices for forward treatment planning and management.
Brachytherapy. 2021 Mar 17. pii: S1538-4721(21)00038.
PubMed
Abstract available

SERBAN M, de Leeuw AAC, Tanderup K, Jurgenliemk-Schulz IM, et al
Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
Brachytherapy. 2021 Mar 17. pii: S1538-4721(21)00041.
PubMed
Abstract available

PULKKINEN J, Huhtala H, Kholova I
The role of Pap smear in the diagnostics of endocervical adenocarcinoma.
APMIS. 2021;129:195-203.
PubMed
Abstract available

KODAMA K, Yahata H, Okugawa K, Tomonobe H, et al
Prognostic outcomes and risk factors for recurrence after laser vaporization for cervical intraepithelial neoplasia: a single-center retrospective study.
Int J Clin Oncol. 2021;26:770-776.
PubMed
Abstract available

NNAJI CA, Kuodi P, Walter FM, Moodley J, et al
Effectiveness of interventions for improving timely diagnosis of breast and cervical cancers in low and middle-income countries: a systematic review protocol.
BMJ Open. 2020;10:e042788.
PubMed
Abstract available

FISHER H, Audrey S, Chantler T, Finn A, et al
Co-production of an educational package for the universal human papillomavirus (HPV) vaccination programme tailored for schools with low uptake: a participatory study protocol.
BMJ Open. 2020;10:e039029.
PubMed
Abstract available

XIE Z, Wang F, Lin L, Duan S, et al
An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells.
Cancer Lett. 2020 Sep 12. pii: S0304-3835(20)30467.
PubMed
Abstract available

GONCHARENKO AA, Tarasyuk IA, Marfin YS, Grzhegorzhevskii KV, et al
DDAO Controlled Synthesis of Organo-Modified Silica Nanoparticles with Encapsulated Fluorescent Boron Dipyrrins and Study of Their Uptake by Cancerous Cells.
Molecules. 2020;25.
PubMed
Abstract available

LIN YC, Chen YC, Chen RY, Huang YX, et al
Genomic Biomarkers of Survival in Patients with Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy.
Int J Mol Sci. 2020;21.
PubMed
Abstract available

KIM N, Chang JS, Kim YB, Kim JS, et al
Atlas-based auto-segmentation for postoperative radiotherapy planning in endometrial and cervical cancers.
Radiat Oncol. 2020;15:106.
PubMed
Abstract available

NGUYEN MH, Nguyen DT, Nguyen PTM
Apoptosis induction by alpha-mangostin-loaded nanoparticles in human cervical carcinoma cells.
Z Naturforsch C J Biosci. 2020;75.
PubMed
Abstract available

CHEN R, Wong E, Wu L, Zhu Y, et al
Toward universal human papillomavirus vaccination for adolescent girls in Hong Kong: a policy analysis.
J Public Health Policy. 2020;41:170-184.
PubMed
Abstract available

KARAKUS SELCUK A, Yanikkerem E
The effect of web-based education on Pap smear behaviours of teachers.
Eur J Cancer Care (Engl). 2020;29:e13202.
PubMed
Abstract available

DAWIDOWICZ S, Le Breton J, Moscova L, Renard V, et al
Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmesdagger.
Fam Pract. 2020;37:15-24.
PubMed
Abstract available

MENG Q, Zhang R, Ding W, Mao B, et al
Long noncoding RNA ZFAS1 promotes cell proliferation and tumor growth by upregulating LIN28 in cervical carcinoma.
Minerva Med. 2020;111:511-514.
PubMed

HAMMER A, Gravitt P
Clinical implications of transitioning from cytology to human papillomavirus-based cervical cancer screening.
Acta Obstet Gynecol Scand. 2021;100:371-372.
PubMed

KYRGIOU M, Arbyn M, Bergeron C, Bosch FX, et al
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC).
Br J Cancer. 2020;123:510-517.
PubMed
Abstract available

HALLE MK, Sodal M, Forsse D, Engerud H, et al
A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.
Br J Cancer. 2021 Mar 15. pii: 10.1038/s41416-021-01305.
PubMed
Abstract available

ARBYN M, Rezhake R, Yuill S, Canfell K, et al
Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence.
Br J Cancer. 2020 Apr 3. pii: 10.1038/s41416-020-0787.
PubMed
Abstract available

CHEN J, Chen C, Zhan Y, Zhou L, et al
Heterogeneity of interferon-mediated responses and tumor immunogenicity in cervical cancer patients receiving concurrent chemoradiotherapy.
Clin Cancer Res. 2021 Mar 25. pii: 1078-0432.CCR-20-4521.
PubMed
Abstract available

LIU W, Gong J, Xu H, Zhang D, et al
Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
Diagn Cytopathol. 2020;48:635-644.
PubMed
Abstract available

MATSUO K, Shimada M, Matsuzaki S, Enomoto T, et al
Wait-time for adjuvant radiotherapy and oncologic outcome in early-stage cervical cancer: A treatment implication during the coronavirus pandemic.
Eur J Cancer. 2021;148:117-120.
PubMed

SKORSTENGAARD M, Frederiksen ME, Baillet MV, Beau AB, et al
Cervical cancer survivors and health care use: A Danish population-based register study.
Gynecol Oncol. 2021 Feb 19. pii: S0090-8258(21)00139.
PubMed
Abstract available

CHANG CL, Ho SC, Su YF, Juan YC, et al
DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Gynecol Oncol. 2021 Mar 20. pii: S0090-8258(21)00148.
PubMed
Abstract available

ALHOLM Z, Monk BJ, Ting J, Pulgar S, et al
Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
Gynecol Oncol. 2021 Mar 16. pii: S0090-8258(21)00194.
PubMed
Abstract available

HALL MT, Smith MA, Simms KT, Barnabas R, et al
Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.
Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33533.
PubMed
Abstract available

CHINULA L, Topazian HM, Mapanje C, Varela A, et al
Uptake and safety of community-based 'screen-and-treat' with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi.
Int J Cancer. 2021 Mar 9. doi: 10.1002/ijc.33549.
PubMed
Abstract available

LOOPIK DL, Ebisch RM, IntHout J, Melchers WJ, et al
The relative risk of noncervical high-risk human papillomavirus-related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population-based study.
Int J Cancer. 2020;147:897-900.
PubMed
Abstract available

WALPOLE E, Dunn N, Youl P, Harden H, et al
Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
Int J Cancer. 2020;147:856-865.
PubMed
Abstract available

LOUVANTO K, Eriksson T, Gray P, Apter D, et al
Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women.
Int J Cancer. 2020;147:440-447.
PubMed
Abstract available

SAND FL, Kjaer SK, Frederiksen K, Dehlendorff C, et al
Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status.
Int J Cancer. 2019 Oct 24. doi: 10.1002/ijc.32752.
PubMed
Abstract available

CASTLE PE, Burk RD, Massad LS, Eltoum IE, et al
Epidemiological Evidence that Common HPV Types May Be Common Because of Their Ability to Evade Immune Surveillance: Results from the Women's Interagency HIV Study.
Int J Cancer. 2019 Oct 2. doi: 10.1002/ijc.32693.
PubMed
Abstract available

PONTI A, Basu P, Ritchie D, Anttila A, et al
Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening.
Int J Cancer. 2020;147:9-13.
PubMed
Abstract available

KUMAR S, Khanduri A, Sidibe A, Morgan C, et al
Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
Int J Gynaecol Obstet. 2020 Nov 13. doi: 10.1002/ijgo.13482.
PubMed
Abstract available

CHUNG MH, De Vuyst H, Greene SA, Topazian HM, et al
Loop electrosurgical excision procedure (LEEP) plus top hat for HIV-infected women with endocervical intraepithelial neoplasia in Kenya.
Int J Gynaecol Obstet. 2021;152:118-124.
PubMed
Abstract available

LIU P, Dai E, Li W, He F, et al
Effect of pre-operative radiotherapy on long-term outcomes among women with Stage IB1 to IIB cervical squamous cell carcinoma.
Int J Gynaecol Obstet. 2021;152:125-132.
PubMed
Abstract available

BUSS LF, Levi JE, Longatto-Filho A, Cohen DD, et al
Attendance for diagnostic colposcopy among high-risk human papillomavirus positive women in a Brazilian feasibility study.
Int J Gynaecol Obstet. 2021;152:72-77.
PubMed
Abstract available

LI Y, Wang H, Zhang Y, Jing X, et al
Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade.
Int J Gynaecol Obstet. 2021;152:96-102.
PubMed
Abstract available

YANG Y, Hu T, Ming X, Yang E, et al
REBACIN(R) is an optional intervention for persistent high-risk human papillomavirus infection: A retrospective analysis of 364 patients.
Int J Gynaecol Obstet. 2021;152:82-87.
PubMed
Abstract available

CAMPITELLI M, Lazzari R, Piccolo F, Ferrazza P, et al
Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review.
Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2020-002310.
PubMed
Abstract available

MCCORMACK M, Gaffney D, Tan D, Bennet K, et al
The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.
Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2021-002422.
PubMed
Abstract available

FURUSAWA A, Takekuma M, Mori K, Usami T, et al
A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
Int J Gynecol Cancer. 2021 Mar 4. pii: ijgc-2020-002344.
PubMed
Abstract available

LOPEZ A, Rodriguez J, Estrada E, Aragona A, et al
Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.
Int J Gynecol Cancer. 2021;31:468-474.
PubMed
Abstract available

MARTINELLI F, Ditto A, Filippi F, Vinti D, et al
Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
Int J Gynecol Cancer. 2021;31:457-461.
PubMed
Abstract available

FANFANI F, Pedone Anchora L, Di Martino G, Bizzarri N, et al
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
Int J Gynecol Cancer. 2021;31:452-456.
PubMed
Abstract available

NICA A, Marchocki Z, Gien LT, Kupets R, et al
Cervical conization and lymph node assessment for early stage low-risk cervical cancer.
Int J Gynecol Cancer. 2021;31:447-451.
PubMed
Abstract available

NOLL F, Palacios Torres AT, Pecci P, Lucchini SM, et al
Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
Int J Gynecol Cancer. 2021;31:379-386.
PubMed
Abstract available

BUONOMO B, Multinu F, Casarin J, Betella I, et al
Ovarian transposition in patients with cervical cancer prior to pelvic radiotherapy: a systematic review.
Int J Gynecol Cancer. 2021;31:360-370.
PubMed
Abstract available

CIBULA D
Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer.
Int J Gynecol Cancer. 2021 Mar 18. pii: ijgc-2021-002510.
PubMed

SORMANI J, Datchoua AM, Petignat P, Kenfack B, et al
Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
Int J Gynecol Cancer. 2021 Mar 12. pii: ijgc-2021-002555.
PubMed

LI R, Liu Y, Yin R, Yin L, et al
The Dynamic alternation of Local and Systemic Tumor Immune Microenvironment during Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00243.
PubMed
Abstract available

YOU X, Wang Y, Meng J, Han S, et al
Exosomal miR663b exposed to TGFbeta1 promotes cervical cancer metastasis and epithelialmesenchymal transition by targeting MGAT3.
Oncol Rep. 2021;45:1.
PubMed
Abstract available

SI J, Zhang J, Gan L, Guo M, et al
The effects of the Wnt/betacatenin signaling pathway on apoptosis in HeLa cells induced by carbon ion irradiation.
Oncol Rep. 2020;44:303-312.
PubMed
Abstract available

WANG J, Xiang F, Liu X, Ma X, et al
HPV E7 affects the function of cervical cancer cells via the TAL1/lncEBIC/KLHDC7B axis.
Oncol Rep. 2021;45.
PubMed
Abstract available

YANG X, Du H, Bian W, Li Q, et al
FOXD3AS1/miR1283p/LIMK1 axis regulates cervical cancer progression.
Oncol Rep. 2021;45.
PubMed
Abstract available

HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
Brachytherapy for locally advanced cervical cancer: a survey of UK provision of care and support.
Radiother Oncol. 2021 Mar 16. pii: S0167-8140(21)06133.
PubMed
Abstract available

KNAUL FM, Doubova SV, Gonzalez Robledo MC, Durstine A, et al
Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study.
BMC Cancer. 2020;20:577.
PubMed
Abstract available

ARARSA T, Tadele N, Ayalew Y, Gela D, et al
Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey.
BMC Cancer. 2021;21:224.
PubMed
Abstract available

YANG E, Huang S, Ran X, Huang Y, et al
The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
BMC Cancer. 2021;21:203.
PubMed
Abstract available

JU Z, Guo W, Gu S, Zhou J, et al
CT based automatic clinical target volume delineation using a dense-fully connected convolution network for cervical Cancer radiation therapy.
BMC Cancer. 2021;21:243.
PubMed
Abstract available

KELLY HA, Chikandiwa A, Sawadogo B, Gilham C, et al
Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
PLoS Med. 2021;18:e1003528.
PubMed
Abstract available

MANYAU PMC, Mabeka M, Mudzviti T, Kadzatsa W, et al
Renal function impairment in cervical cancer patients treated with cisplatin-based chemoradiation: A review of medical records in a Zimbabwean outpatient department.
PLoS One. 2021;16:e0245383.
PubMed
Abstract available

DEVINE A, Vahanian A, Sawadogo B, Zan S, et al
Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study.
PLoS One. 2021;16:e0248832.
PubMed
Abstract available

TOYODA Y, Tabuchi T, Hama H, Morishima T, et al
Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
PLoS One. 2020;15:e0244644.
PubMed
Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:

;